LIMITED LIABILITY COMPANY AGREEMENT OF FRESENIUS KABI PHARMACEUTICALS HOLDING, LLCLimited Liability Company Agreement • August 1st, 2008 • Fresenius Kabi Pharmaceuticals Holding, LLC • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT (the “Agreement”) of FRESENIUS KABI PHARMACEUTICALS HOLDING, LLC (the “Company”) dated as of this 2nd day of July, 2008, by FRESENIUS KABI AKTIENGESELLSCHAFT, as the sole member of the Company (the “Member”).
NON-COMPETITION AGREEMENTNon-Competition Agreement • August 1st, 2008 • Fresenius Kabi Pharmaceuticals Holding, LLC • California
THIS NON-COMPETITION AGREEMENT (this “Agreement”) is entered into as of July 6, 2008, by and between Fresenius SE, a societas europaea organized under the laws of Germany (the “Company”), and Dr. Patrick Soon-Shiong (“Shareholder”), a shareholder of APP Pharmaceuticals, Inc., a Delaware corporation (“APP”).
Fresenius SE 61346 Bad Homburg v.d.H.Equity Commitment • August 1st, 2008 • Fresenius Kabi Pharmaceuticals Holding, LLC
CONSULTING AGREEMENTConsulting Agreement • August 1st, 2008 • Fresenius Kabi Pharmaceuticals Holding, LLC • California
THIS CONSULTING AGREEMENT (the “Agreement”) is entered into as of July 6, 2008, by and between Fresenius Kabi Pharmaceuticals Holding, LLC, a Delaware limited liability company (the “Company”), Dr. Patrick Soon-Shiong (“Consultant”) and Fresenius SE, a societas europaea organized under the laws of Germany (“Parent,” and together with the Company and Consultant, the “Parties”), and sets forth the terms and conditions governing the consulting relationship between the Parties:
